These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
288 related articles for article (PubMed ID: 29499737)
1. Comparison of benign peritoneal fluid- and ovarian cancer ascites-derived extracellular vesicle RNA biomarkers. Yamamoto CM; Oakes ML; Murakami T; Muto MG; Berkowitz RS; Ng SW J Ovarian Res; 2018 Mar; 11(1):20. PubMed ID: 29499737 [TBL] [Abstract][Full Text] [Related]
2. Microparticles from ovarian carcinomas are shed into ascites and promote cell migration. Press JZ; Reyes M; Pitteri SJ; Pennil C; Garcia R; Goff BA; Hanash SM; Swisher EM Int J Gynecol Cancer; 2012 May; 22(4):546-52. PubMed ID: 22315094 [TBL] [Abstract][Full Text] [Related]
3. Integrated analysis of ascites and plasma extracellular vesicles identifies a miRNA-based diagnostic signature in ovarian cancer. Wang W; Jo H; Park S; Kim H; Kim SI; Han Y; Lee J; Seol A; Kim J; Lee M; Lee C; Dhanasekaran DN; Ahn T; Song YS Cancer Lett; 2022 Aug; 542():215735. PubMed ID: 35569696 [TBL] [Abstract][Full Text] [Related]
4. Biologically Active Tissue Factor-Bearing Larger Ectosome-Like Extracellular Vesicles in Malignant Effusions from Ovarian Cancer Patients: Correlation with Incidence of Thrombosis. Steidel C; Ender F; Rody A; von Bubnoff N; Gieseler F Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33466775 [TBL] [Abstract][Full Text] [Related]
5. Higher EpCAM-Positive Extracellular Vesicle Concentration in Ascites Is Associated with Shorter Progression-Free Survival of Patients with Advanced High-Grade Serous Carcinoma. Herzog M; Verdenik I; Kobal B; Černe K Int J Mol Sci; 2024 Jun; 25(12):. PubMed ID: 38928484 [TBL] [Abstract][Full Text] [Related]
6. EV-associated miRNAs from peritoneal lavage as potential diagnostic biomarkers in colorectal cancer. Roman-Canal B; Tarragona J; Moiola CP; Gatius S; Bonnin S; Ruiz-Miró M; Sierra JE; Rufas M; González E; Porcel JM; Gil-Moreno A; Falcón-Pérez JM; Ponomarenko J; Matias-Guiu X; Colas E J Transl Med; 2019 Jun; 17(1):208. PubMed ID: 31221189 [TBL] [Abstract][Full Text] [Related]
7. Extracellular vesicle-associated miRNAs in ovarian cancer - design of an integrated NGS-based workflow for the identification of blood-based biomarkers for platinum-resistance. Kuhlmann JD; Chebouti I; Kimmig R; Buderath P; Reuter M; Puppel SH; Wimberger P; Kasimir-Bauer S Clin Chem Lab Med; 2019 Jun; 57(7):1053-1062. PubMed ID: 30422797 [TBL] [Abstract][Full Text] [Related]
8. Inflammation-regulating factors in ascites as predictive biomarkers of drug resistance and progression-free survival in serous epithelial ovarian cancers. Lane D; Matte I; Garde-Granger P; Laplante C; Carignan A; Rancourt C; Piché A BMC Cancer; 2015 Jul; 15():492. PubMed ID: 26122176 [TBL] [Abstract][Full Text] [Related]
9. Proteomic analysis of ascitic extracellular vesicles describes tumour microenvironment and predicts patient survival in ovarian cancer. Vyhlídalová Kotrbová A; Gömöryová K; Mikulová A; Plešingerová H; Sladeček S; Kravec M; Hrachovinová Š; Potěšil D; Dunsmore G; Blériot C; Bied M; Kotouček J; Bednaříková M; Hausnerová J; Minář L; Crha I; Felsinger M; Zdráhal Z; Ginhoux F; Weinberger V; Bryja V; Pospíchalová V J Extracell Vesicles; 2024 Mar; 13(3):e12420. PubMed ID: 38490958 [TBL] [Abstract][Full Text] [Related]
10. Extracellular vesicles derived from ascitic fluid enhance growth and migration of ovarian cancer cells. Mitra A; Yoshida-Court K; Solley TN; Mikkelson M; Yeung CLA; Nick A; Lu K; Klopp AH Sci Rep; 2021 Apr; 11(1):9149. PubMed ID: 33911091 [TBL] [Abstract][Full Text] [Related]
11. EV-Associated MMP9 in High-Grade Serous Ovarian Cancer Is Preferentially Localized to Annexin V-Binding EVs. Reiner AT; Tan S; Agreiter C; Auer K; Bachmayr-Heyda A; Aust S; Pecha N; Mandorfer M; Pils D; Brisson AR; Zeillinger R; Lim SK Dis Markers; 2017; 2017():9653194. PubMed ID: 28607529 [TBL] [Abstract][Full Text] [Related]
12. Targeted proteomics of plasma extracellular vesicles uncovers MUC1 as combinatorial biomarker for the early detection of high-grade serous ovarian cancer. Cooper TT; Dieters-Castator DZ; Liu J; Siegers GM; Pink D; Veliz L; Lewis JD; Lagugné-Labarthet F; Fu Y; Steed H; Lajoie GA; Postovit LM J Ovarian Res; 2024 Jul; 17(1):149. PubMed ID: 39020428 [TBL] [Abstract][Full Text] [Related]
13. RNA biomarkers from proximal liquid biopsy for diagnosis of ovarian cancer. Hulstaert E; Levanon K; Morlion A; Van Aelst S; Christidis AA; Zamar R; Anckaert J; Verniers K; Bahar-Shany K; Sapoznik S; Vandesompele J; Mestdagh P Neoplasia; 2022 Feb; 24(2):155-164. PubMed ID: 34998206 [TBL] [Abstract][Full Text] [Related]
14. Vascular endothelial growth factor activating matrix metalloproteinase in ascitic fluid during peritoneal dissemination of ovarian cancer. Yabushita H; Shimazu M; Noguchi M; Kishida T; Narumiya H; Sawaguchi K; Noguchi M Oncol Rep; 2003; 10(1):89-95. PubMed ID: 12469150 [TBL] [Abstract][Full Text] [Related]
15. Deep Sequencing of Small RNAs from Neurosurgical Extracellular Vesicles Substantiates miR-486-3p as a Circulating Biomarker that Distinguishes Glioblastoma from Lower-Grade Astrocytoma Patients. Hallal S; Ebrahim Khani S; Wei H; Lee MYT; Sim HW; Sy J; Shivalingam B; Buckland ME; Alexander-Kaufman KL Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32668808 [TBL] [Abstract][Full Text] [Related]
16. Exosomal miRNAs from Peritoneum Lavage Fluid as Potential Prognostic Biomarkers of Peritoneal Metastasis in Gastric Cancer. Tokuhisa M; Ichikawa Y; Kosaka N; Ochiya T; Yashiro M; Hirakawa K; Kosaka T; Makino H; Akiyama H; Kunisaki C; Endo I PLoS One; 2015; 10(7):e0130472. PubMed ID: 26208314 [TBL] [Abstract][Full Text] [Related]
17. Transketolase is upregulated in metastatic peritoneal implants and promotes ovarian cancer cell proliferation. Ricciardelli C; Lokman NA; Cheruvu S; Tan IA; Ween MP; Pyragius CE; Ruszkiewicz A; Hoffmann P; Oehler MK Clin Exp Metastasis; 2015 Jun; 32(5):441-55. PubMed ID: 25895698 [TBL] [Abstract][Full Text] [Related]
19. Comparative proteomic analysis of human malignant ascitic fluids for the development of gastric cancer biomarkers. Jin J; Son M; Kim H; Kim H; Kong SH; Kim HK; Kim Y; Han D Clin Biochem; 2018 Jun; 56():55-61. PubMed ID: 29654727 [TBL] [Abstract][Full Text] [Related]